Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Nabi signs distribution agreement with Kamada for Nabi-HB

Feb. 12, 2004

Probactrix IBS trial commences enrollment

Feb. 10, 2004

Micrologix Biotech acquires celgosivir rights

Feb. 10, 2004

Another series of HCV NS5B inhibitors presented by Merck and Isis researchers

Feb. 9, 2004

Tillotts and Zeria sign Japanese agreement for Asacol

Feb. 9, 2004

Takeda describes new prodrugs of proton pump inhibitors and their use

Feb. 5, 2004

Genencor hepatitis B vaccine to enter phase I this month

Feb. 4, 2004

Merck and Isis present new NS5B inhibitors for use in HCV infection

Feb. 4, 2004

Probactrix well tolerated and safe in safety study

Feb. 3, 2004

Phase III program under way for Viramidine

Feb. 2, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...